Prostate cancer patients disease free after 5 years likely to be disease free after 10 years

Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news165761251.html">Prostate cancer patients disease free after 5 years likely to be disease free after 10 years</a></p> <p>Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the <i>International Journal of Radiation Oncology*Biology*Physics</i>, the official journal of the American Society for Radiation Oncology (ASTRO).</p>